Buy Glenmark Pharma, Lupin: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Pharmaceutical is something that is coming out of a correction. There is a problem with pharmaceutical also and that problem is that if the Nifty is not cheerful as it is not today, then pharmaceutical alone does not go up as much as it can. However, at least it works as a defensive buying opportunity and for individual reason also pharmaceutical stocks can sometimes go up.""There is a buy in Glenmark Pharma and Lupin. All of these stocks suggest that higher levels are coming. I don’t know much about how intraday they would behave because on intraday sometimes the Nifty can carry all the positions towards it. However, over a period of time for the next few days, pharmaceutical stocks should be cheerful," he said.